IRIS
DI STASI, SAVINO MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.891
EU - Europa 4.119
AS - Asia 860
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 9
OC - Oceania 8
Totale 55.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 50.854
IT - Italia 1.044
UA - Ucraina 796
DE - Germania 562
FR - Francia 558
IE - Irlanda 494
CN - Cina 429
KR - Corea 222
SE - Svezia 195
FI - Finlandia 170
GB - Regno Unito 136
PL - Polonia 67
VN - Vietnam 63
RU - Federazione Russa 43
JP - Giappone 40
CA - Canada 28
CL - Cile 23
HK - Hong Kong 22
IN - India 19
SG - Singapore 18
EU - Europa 13
NL - Olanda 12
ES - Italia 11
MX - Messico 9
BR - Brasile 8
KG - Kirghizistan 8
EG - Egitto 7
AU - Australia 6
IL - Israele 6
TR - Turchia 6
IR - Iran 5
AT - Austria 4
BE - Belgio 4
GR - Grecia 4
RO - Romania 4
UZ - Uzbekistan 4
HU - Ungheria 3
ID - Indonesia 3
CH - Svizzera 2
GE - Georgia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
TH - Thailandia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 55.932
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.344
Wilmington 14.971
Houston 12.776
Fairfield 1.248
Ann Arbor 734
Jacksonville 708
Ashburn 505
Dublin 487
Seattle 475
Chandler 463
Cambridge 401
Medford 380
Dearborn 239
Beijing 206
Lawrence 179
Rome 138
Mülheim 112
Menlo Park 77
Kraków 65
Milan 60
San Diego 58
Dong Ket 55
New York 55
University Park 49
Phoenix 47
Seongnam 41
Zhengzhou 38
Falls Church 31
London 26
Helsinki 21
Seoul 21
Hefei 19
Norwalk 19
Guangzhou 18
Hong Kong 18
Nanjing 18
Naples 18
Redwood City 18
Verona 18
Temuco 15
Kunming 13
Shanghai 13
Boardman 12
Jinan 12
Bologna 11
Mountain View 11
Council Bluffs 10
Florence 10
Kilburn 10
Munich 9
Saint Petersburg 9
Shenyang 9
Toronto 9
Turin 9
Casoria 8
Engelhard 8
Redmond 8
San Mateo 8
Cagliari 7
Chicago 7
Hanoi 7
Bari 6
Center 6
Creede 6
Frankfurt am Main 6
Fuzhou 6
Genoa 6
Kyiv 6
Los Angeles 6
Mcallen 6
Mexico 6
Napoli 6
Nürnberg 6
Wuhan 6
Fasano 5
Hangzhou 5
Indiana 5
Monza 5
San Francisco 5
San Giorgio a Cremano 5
Shaoxing 5
Tokyo 5
Torino 5
Anzio 4
Baronissi 4
Catania 4
Groningen 4
Hebei 4
Kisa 4
Ningbo 4
Ottawa 4
Perugia 4
Rimini 4
San Prospero 4
Aci Sant'antonio 3
Aix-en-Provence 3
Amsterdam 3
Ardabil 3
Barcelona 3
Brooklyn 3
Totale 51.556
Salva come PNG Salva come JPEG
Nome #
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 594
Cisti intraparenchimali del didimo: aspetti ecografici. 474
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo 458
L’ecocolor Doppler nella diagnosi di prostatite granulomatosa especifica: esperienza personale. 451
Updates in intravesical electromotive drug administration(A (R)) of mitomycin-C for non-muscle invasive bladder cancer 446
Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer 440
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 431
L'Ecografia nella diagnosi dei diverticoli dell'uretra femminile. 428
Prevalence of chronic prostatitis in men with premature ejaculation. 427
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder 419
Concentration-depth profiles of mitomycin-C in the human bladder wall after passive diffusion, thermochemotherapy, and electromotive drug administration. 418
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 411
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. 406
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 405
New Frontiers in Intravesical Therapies and Drug Delivery 401
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 400
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study 399
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study 395
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 393
Electromotive delivery of mitomycin C into human bladder wall 393
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. 392
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette-guerin for non-muscle-invasive bladder cancer 391
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 391
Alfa-2a-interferon in neoadjuvant and adjuvant therapy of superficial ladder cancer: preliminary results. 391
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. 390
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. 389
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens 388
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys 387
Pelvic floor muscle behavior during Valsalva leak point pressure measurement in males and females affected by stress urinary incontinence. 387
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 386
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. 385
Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial. 385
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer 385
Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial 384
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. 384
Tissue pharmacokinetics of mitomycin-c in the human bladder wall after passive diffusion, thermo-chemotherapy and electromotive drug administration. 384
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 383
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients 383
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 382
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo. 382
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 381
Single immediate preoperative intravesical instillation of electromotive mitomycin-C for low risk superficial bladder cancer: A prospective randomized study. 381
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. 380
Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer 379
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial 378
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. 378
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. 378
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. 377
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 376
Diverticoli uretrali ed ascessi parauretrali nella donna: nostra esperienza. 374
Electromotive administration of oxybutynin into the human bladder wall. 370
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 367
Electromotive delivery of mitomycin C into human bladder wall 366
Intravesical sequential BCG and electromotive mitomycin versus BCG alone in high risk non-muscle invasive bladder cancer 365
Contemporary management of non-muscle invasive bladder cancer at italian referral centres adopting eau guidelines 365
Percutaneous sequential bacillus Calmette-Guérin and mitomycin C for panurothelial carcinomatosis. 364
Intravesical sequential bacillus Calmette-Guérin and electromotive mitomycin versus bacillus Calmette-Guérin alone for stage pt1 urothelial bladder cancer 363
Intravesical electromotive drug administration. 362
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 359
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys. 358
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 357
Urodynamic assessment of bladder and urethral sphincter function before radical prostatectomy and during long-term follow-up. 357
The human bladder urothelium: new concepts and future perspectives. 357
Tumori vescicali intradiverticolari. Diagnosi preoperatoria. 355
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study 354
Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. 354
Intravesical electromotive administration of oxybutynin: from laboratoty to clinica field. 353
Gender identity rather than sexual orientation impacts on facial preferences. 352
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction 350
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 349
La terapia intralesionale dei tumori superficiali a cellule transizionali della vescica con interferone alfa ricombinante 349
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 348
Autonomic dysreflexia during urodynamics 347
The bladder urothelium: passive permeabilità and intravesical drug passive diffusion. 347
Single preoperative intravesical instillation of electromotive anitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randonsied trial 347
Malattia di La Peyronie. 346
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis 345
Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience. 345
Our experience with Epirubicin in the treatmnet of superficial bladder tumors after conservative therapy. 344
Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer 343
BCG nel carcinoma vescicale 343
Intravesical Sequential BCG and Elecromotive Mitomycin-C versus BCG Alone for Stage pT1 Urothelial Bladder Cancer. 343
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass. 342
Intravesical electro-osmotic administration of mitomycin C 342
Adjuvant alpha-interferon in renal cell carcinoma at high risk of relapse. A multicentre pilot study. 339
Valsalva leak point pressure 339
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. 338
Extracorporeal piezoelectric lithotripsy: experience in 930 patients. 338
Long-term followup analysis of a randomized prospective study comparing intravesical electromotive mitomycin-C, passive diffusion mitomycin-C and bacillus Calmette-Guerin in patients with carcinoma in situ of the bladder. 338
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 337
Intravesical baobab oil in the management of bcg-induced lower urinary tract symptoms 336
Urodynamics in spinal cord injured patients walking with reciprocating gait orthosis. 333
Il drenaggio percutaneo ecoguidato transperineale delle raccolte pelviche 333
Immunotherapy or chemotherapy as local therapy of urinary bladder cancer - which is the most effective? report on a meta-analysis of the long-term outcome of randomized studies comparing intravesical mitomycin c versus bacillus calmette-guerin for non-muscle invasive bladder cancer. 332
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. 332
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis. 330
Neoplasia prostatica: rapporto tra evoluzione locale e sistemica. 330
Prognostic factors and risk groups in T1G3 patients initially treated with BCG: Results of a multicenter retrospective series in 1743 patients 330
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 329
L'interferone alfa-2a ricombinante nel trattamento e nella profilassi delle neoplasie superficiali a cellule transizionali della vescica. Studio di fase I e II. 329
Totale 37.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.419 0 0 0 0 0 0 0 0 0 1.361 1.523 1.535
2019/202016.043 1.502 1.371 1.269 1.352 1.353 1.633 1.348 1.419 1.234 1.344 984 1.234
2020/20218.887 1.012 1.154 978 1.263 792 972 1.124 771 213 141 346 121
2021/20221.686 51 251 86 120 63 92 95 77 109 129 80 533
2022/20231.761 218 104 52 155 123 434 191 97 114 40 178 55
2023/2024618 71 41 83 49 53 99 91 47 43 41 0 0
Totale 56.306